Literature DB >> 32142

Phytohemagglutinin stimulation of enhanced immunoglobulin G production in mice inoculated with type III pneumococcal polysaccharide.

S N Vogel, B S Roberson.   

Abstract

In BALB/c mice previously inoculated intraperitoneally with an immunogenic dose of the T-independent antigen type III pneumococcal polysaccharide, the intravenous administration of the T-cell activating agent phytohemagglutinin P causes a pronounced increase in the number and relative proportion of immunoglobulin G-producing cells. These results, detected by a modified hemolytic plaque assay, were supported by finding increased levels of serum immunoglobulin G anti-type III pneumococcal polysaccharide in the treated mice. A comparable stimulation of immunoglobulin G antibody-producing cells was not induced in phytohemagglutinin P-treated nude mice, indicating that the change in class of the predominant antibody is attributable to the activation by the phytohemagglutinin P of a T-cell population. Under the conditions of these experiments, phytohemagglutinin P also promotes a progressive suppression of the antibody-forming cells during the response to type III pneumococcal polysaccharide.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 32142      PMCID: PMC422242          DOI: 10.1128/iai.22.3.901-907.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  The effect of Bordetella pertussis on the antibody response in mice to type III pneumococcal polysaccharide.

Authors:  A S Kong; S I Morse
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

2.  Kinetics of the antibody response to type III pneumococcal polysaccharide (SSS-III). I. Use of 125I-labeled SSS-III to study serum antibody levels, as well as the distribution and excretion of antigen after immunization.

Authors:  J M Jones; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

Review 3.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

4.  Demonstration of activation of B lymphocytes in New Zealand black mice at birth by an immunoradiometric assay for murine IgM.

Authors:  H M Moutsopoulos; M Boehm-Truitt; S S Kassan; T M Chused
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

Review 5.  The class of surface immunoglobulin on virgin and memory B lymphocytes.

Authors:  R L Coffman; M Cohn
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

6.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. II. Mode of action of thymic-derived suppressor cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

7.  Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to type 3 pneumococcal polysaccharide.

Authors:  J G Howard; G H Christie; B M Courtenay; E Leuchars; A J Davies
Journal:  Cell Immunol       Date:  1971-12       Impact factor: 4.868

8.  Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide.

Authors:  H Braley-Mullen
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

9.  Expression of Ia antigens on hapten-specific B cells. I. Delineation of B-cell subpopulations.

Authors:  J L Press; N R Klinman; H O McDevitt
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

10.  Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses.

Authors:  A Coutinho; E Gronowicz; W W Bullock; G Möller
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  1 in total

1.  Humoral immune response in chinchillas to the capsular polysaccharides of Streptococcus pneumoniae.

Authors:  G S Giebink; G Schiffman
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.